Filter Results

Clinical Studies


Closed for Enrollment

  • Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma Jacksonville, Fla.

    The purpose of this study is to obtain de-identified, clinically-characterized whole blood specimens for use in developing and evaluating the performance of new biomarker assays for detection of hepatocellular carcinoma (HCC).

  • Circulating Nucleic Acid Based Biomarkers for Early Detection of HCC Jacksonville, Fla.

    The goals of this study are to establish the role of circulating nucleic acid based biomarkers in early diagnosis, prognosis or treatment response in human diseases. These studies will determine whether alterations in circulating nucleic acids can distinguish between healthy and cancer tissue. 

  • Extracellular RNA Markers of Liver Disease and Cancer Rochester, Minn., Jacksonville, Fla.

    This study is being done to collect and store samples of blood from patients with liver disease for a research study to be able to find a new and better way to detect liver cancer.

  • HCC Recurrence After Liver Transplantation Jacksonville, Fla.

    The purpose of this study is evaluation of tumoral markers at the time of transplant to assess recurrence risk, and assessment of tumor sensitivity to a panel of candidate therapeutics as a guide to adjunct or therapeutic therapies for recurrent hepatocellular cancers (HCC).  

  • Pilot Study of EGFR Inhibition With Erlotinib in Cirrhosis to Inhibit Fibrogenesis and Prevent Hepatocellular Carcinoma Rochester, Minn., Jacksonville, Fla.

    This pilot clinical trial studies the best dose of erlotinib hydrochloride and to see how well it works in preventing liver cancer in patients with scarring (cirrhosis) of the liver undergoing surgery. Erlotinib hydrochloride may help to inhibit the development of fibrous tissue and prevent liver cancer from forming in patients with cirrhosis of the liver.